Home › Cancro colorettale › Washington › Seattle
Studi clinici su Cancro colorettale a Seattle, WA
34 studi su Cancro colorettale cercano partecipanti presso sedi a Seattle e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
In reclutamentoFase 3
- University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 281451, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
In reclutamentoFase 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- e altri 1
Family Communications After Genetic Testing
In reclutamentoVolontari sani benvenuti
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- e altri 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
In reclutamentoFase 1
- Fred Hutchinson Cancer Center, Seattle
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
In reclutamentoFase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
In reclutamentoFase 2
- Virginia Mason Medical Center, Seattle
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
In reclutamentoFase 2
- University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 271298, Seattle
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
In reclutamentoFase 3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center, Seattle
- e altri 1
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
In reclutamentoStudio osservazionale
- Fred Hutchinson Cancer Center, Seattle
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
In reclutamentoFase 1
- Swedish Cancer Institute, Seattle
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
In reclutamentoFase 3
- Fred Hutchinson Cancer Research Center, Seattle
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
In reclutamentoFase 3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
In reclutamentoFase 2/3
- Local Institution - 0253, Seattle
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
In reclutamentoFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
In reclutamentoFase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
In reclutamento
- Benaroya Research Institute at Virginia Mason, Seattle
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
In reclutamentoFase 2
- Swedish Cancer Institute, Seattle
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
In reclutamentoFase 1
- Fred Hutchinson Cancer Center, Seattle
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
In reclutamentoStudio osservazionale
- University of Washington, Seattle
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
In reclutamentoFase 1
- Fred Hutchinson Cancer Center, Seattle
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
In reclutamentoFase 1
- University Of Washington, Seattle
A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
In reclutamentoVolontari sani benvenuti
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- Fred Hutchinson Cancer Center, Seattle
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
In reclutamentoFase 1
- Fred Hutchinson Cancer Center, Seattle
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
In reclutamentoFase 1/2
- Virginia Mason Medical Center, Seattle
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
In reclutamentoFase 1/2
- Virginia Mason Medical Center, Seattle
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
In reclutamentoFase 3Volontari sani benvenuti
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- e altri 1
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
In reclutamentoFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Kaiser Permanente Washington, Seattle
- Swedish Medical Center-First Hill, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- Fred Hutch Cancer Center, Seattle
ColoCare Study - Colorectal Cancer Cohort
In reclutamentoStudio osservazionale
- FHCRC, Seattle
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
In reclutamentoStudio osservazionale
- University of Washington / Fred Hutchinson Cancer Center, Seattle
A Study of IBI363 in Subjects with Advanced Solid Malignancies
In reclutamentoFase 2
- Fred Hutchinson Cancer Center, Seattle
Studi su Cancro colorettale in altre città
- Houston, TX102 studi
- New York City, NY77 studi
- Nashville, TN69 studi
- Boston, MA63 studi
- Los Angeles, CA59 studi
- Arlington, VA52 studi
- St. Louis, MO50 studi
- San Antonio, TX46 studi
- Philadelphia, PA44 studi
- Grand Rapids, MI40 studi
- Baldwin Park, CA38 studi
- Tampa, FL33 studi
Altri studi a Seattle
- Cancro del polmone non a piccole cellule53 studi
- Cancro (tutti i tipi)49 studi
- Cancro alla prostata42 studi
- Leucemia mieloide acuta40 studi
- Cancro al seno39 studi
- Cancro metastatico39 studi
- Cancro ai polmoni33 studi
- Cancro ovarico30 studi
- Mieloma multiplo22 studi
- Sindromi mielodisplastiche21 studi
- Leucemia linfoblastica acuta21 studi
- Cancro della vescica21 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.